Cochrane Abstracts
Methotrexate for juvenile idiopathic arthritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methotrexate for Juvenile Idiopathic Arthritis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432258/all/Methotrexate_for_juvenile_idiopathic_arthritis.
Methotrexate for juvenile idiopathic arthritis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432258/all/Methotrexate_for_juvenile_idiopathic_arthritis. Accessed November 24, 2024.
Methotrexate for juvenile idiopathic arthritis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432258/all/Methotrexate_for_juvenile_idiopathic_arthritis
Methotrexate for Juvenile Idiopathic Arthritis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432258/all/Methotrexate_for_juvenile_idiopathic_arthritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methotrexate for juvenile idiopathic arthritis
ID - 432258
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432258/all/Methotrexate_for_juvenile_idiopathic_arthritis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
